Features
Inpatient Glycemic Management
GlucoStabilizer is an integrated inpatient software for IV insulin management with the mission of improving outcomes, including reducing adverse events associated with hypoglycemia and hyperglycemia.
GlucoStabilizer’s proprietary algorithms for IV adult and pediatric insulin dosing are FDA-cleared.
Management of patients using GlucoStabilizer is made simple with easy integration with existing EHR systems. The use of GlucoStabilizer allows institutions the ability to standardize processes across all areas of IV insulin care and assists in improving clinical and financial outcomes over traditional methods.
The GlucoStabilizer system enables providers to reduce the frequency, risk, and cost of hyperglycemia, hypoglycemia, and glycemic variability for hospitalized patients.
Features
✓ Utilization
GlucoStabilizer is available for use in any inpatient hospital setting, including critical care, step-down, med-surg, ER/ED, and pediatrics. Moving patients from Unit to Unit is made easy with the GlucoStabilizer’s network capabilities. With the number of admitted patients diagnosed with diabetes, prediabetes, or hyperglycemia increasing, GlucoStabilizer provides the necessary support to handle clinical events requiring IV insulin.
✓ Network Integration
GlucoStabilizer’s platform supports seamless integration into an existing health system’s IT network. Compatible with leading Electronic Medical Record (EMR) systems, GlucoStabilizer increases workflow efficiency and eliminates data redundancy. GlucoStabilizer’s reporting tools provide meaningful data to trend key glycemic performance measures and guide hospital-based quality improvement initiatives. Data is accessible directly within the software or via simple export to other reporting systems.
✓ MAINTENANCE AND SUPPORT
GlucoStabilizer assists hospitals in meeting HIPAA requirements, is effortlessly installed on a hospital’s intranet, requires minimal IT maintenance, and creates no additional cost expenditures for hardware. Additionally, upgrading GlucoStabilizer has minimal impact on clinical and IT teams. GlucoStabilizer’s users also have access to clinical and technical support providing unmatched service.
✓ Ease of Use
GlucoStabilizer software provides clinical decision support where intravenous insulin is administered. The clinical environment was carefully considered in the design of GlucoStabilizer’s user-friendly interface. GlucoStabilizer gives providers confidence in treating hyperglycemia safely while minimizing risk for hypoglycemia and glycemic variability.
✓ Safety
GlucoStabilizer’s insulin dosing algorithm, combined with protective computerized rules and alarm features, helps healthcare providers reduce hypoglycemic events.
✓ Patient Treatment
GlucoStabilizer was developed to treat and manage glycemia in all hospitalized patient types including pediatric patients as young as two years of age, as well as other patient populations driven by internal organization protocols. GlucoStabilizer automates the calculation of insulin dosing based on patient glucose results and provides fast, easy, and safe control.
✓ Prandial Insulin Dosing
GlucoStabilizer offers an optional carbohydrate coverage for those patients who are eating while on an IV insulin infusion. The system uses carbohydrate information entered by a medical professional to recommend the appropriate post-prandial insulin treatment.
✓ IV to SubQ Transition
Transitioning a patient off of IV insulin to SubQ insulin is simplified with GlucoStabilizer’s patient-specific transition orders from IV insulin to subcutaneous insulin therapy.
✓ System Configuration
GlucoStabilizer is configurable, providing nearly 40 different variables that can be customized based on your institution’s goals and current standard of care. Medical Administrators have direct access to GlucoStabilizer, allowing for seamless and simple configuration and customization. Different glucose target ranges may be set for different patient populations and custom ranges can be created for different patient types.